Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

VHIR stands out in an h index ranking

Researchers of Vall Hebron Institute de Recerca (VHIR) occupy a prominent position in a ranking that publishes a list of the best Spanish researchers according the h index. It consists on a method that evaluates the impact of scientific research in different areas of knowledge. According to the stud

News

A study explores the relationship between personality patterns and the different subtypes of ADHD

Researchers from Vall d'Hebron Research Institute (VHIR) have established clear relationships between different personality patterns of patients with Attention Deficit Disorder and Hyperactivity Disorder (ADHD) and disorder subtypes that these patients suffer. The results of this study, published

News

The scientific perspective on intersexuality

Dr. Laura Audi, member of the Endicronology Paediatric Unit at Vall d'Hebron Research Institute (VHIR) gives her views on intersexuality. Years ago, it was assigned one sex to the baby that eventually, could be wrong. Now, thanks to advances in genetic, morphological and hormonal studies, is possib

News

Described for the first time a key protein in cell mitosis

A study led by Dr. Rosanna Paciucci, member of the Biomedical Research and traslational Oncology Unit at VHIR, and published in the Journal of Biological Chemistry, describes for the first time how key is Flotilina 1 for the correct separation of chromosomes during cell mitosis. This protein, presen

News

Dr. Montalban opinion about Salvitex on the market

Chief of Clinical Neuroimmunology at Vall d'Hebron Research Institute (VHIR), Dr. Xavier Montalban, talks about the green light from the health authorities to market Sativex in Spain, a drug derived from cannabis for the treatment of spasticity in multiple sclerosis patients.

News

End of Pandemic Influenza A: Reviews of Dr. Rello

As coordinator of the European Registry of severe cases of A influenza, Dr. Rello, Head of Research Group on sepsis and severe respiratory infection of VHIR, summarizes the management of the first pandemic of the XXI century in the tv show 'Els Matins', of TV3.

News

Trobada entre els investigadors del Vall d'Hebron i els IDIAP Jordi Gol

El passat 16 d'abril va tenir lloc la trobada entre investigadors de l'Hospital Vall d'Hebron i investigadors de l'atenció primària de salut de Catalunya, dins del marc de les VII Jornades d'Excel·lència en la Recerca d'Atenció Primària organitzades per l'Institut d'Investigació en Atenció Primària

News

Els fàrmacs orals aterren en el tractament de l'esclerosi múltiple

Tres estudis clínics en fase III amb una àmplia mostra de pacients (cadascun inclou més de mil) han demostrat la clara eficàcia de dues molècules orals, fingolimod i cladribina, davant placebo en el tractament de l'esclerosi múltiple. En el cas de fingolimod, un dels assaigs també indica que és supe

News

ICS Research institutes sign an agreement with B.Braun to develope a program to investigate surgical technology

Three research institutes assigned to Institut català de la salut (ICS),-Germans Trias i Pujol, Vall d’ Hebron and Bellvitge hospitals- have subscribed a research and innovation program with B.Braun Group to help investigation about surgical technology improvement. Each Institut will have a mana

News

VHIR overcomes 70 patents

Diario Medico' points out in a recent article that Vall d'Hebron Research Institute (VHIR) overcomes 70 patents. It is one of the most important items in an article where last VHIR innovations are revised and where Dr. Joan X. Comella, its director, explains the state of several projects. The articl

News

Awarded a segmentary and local child glomeruloesclerosis study

Catalan nephrology society (Societat catalana de nefrologia) has recently granted with best clinic work to a segmentary adn local child glomeruloesclerosis study from Vall d'Hebron Research Institute (VHIR) investigators and paediatric nephrology service from the same hospital. The study includes ne

News

VHIR coordinates a new European Project that studies repetitive spontaneous abortions

Vall d’ Hebron Research Institute (VHIR) coordinates an European register that includes information about antiphospholipid sindrome (APS) associated with bad pregnancy precedents. (spontaneous abortions, fetus deaths, complications during pregnancy…)

News

Dr. Alijotas gives some clues about implants

In a wide interview with Group Vocento 'XL Semanal', Dr Alijoats, responsible of the aging unite at Vall d'Hebron Research Institute, explains his experience with implants.

News

Vall d' Hebron presents research activities and bets for innovation and fundraising

Vall d'Hebron Research Institute presented the report of research activities 2009/10 at the conference’s room at 10th floor in the Hospital General area. The first speaker who initiated the act was the manager of the hospital, Dr. Jose Luis de Sancho. He made a positive evaluation of the work done t

News

Vall d'Hebron Research Institute and Ilimit work together to improve communication between doctors in the CAP and specialists

Vall d'Hebron Research Institute and Ilimit lead the creation of an R & D related to Information Technology (IT) applied to the health sector.

News

Decrypted first human metagenome

Researchers at the Institut de Recerca de l'Hospital Universitari Vall d'Hebron in Barcelona

News

The HUVH makes the first full face transplant in the world

The Vall d’Hebron University Hospital, made the first full face transplant in the world.

News

The International course of sepsis analyses advances in the study of clinical failure

The 2010 International course of sepsis’s edition, which will be held on the 7th and 8th of June, will be about the advances in the study of clinic failure. The course, organised by 2 groups of Ciber respiratory diseases (CIBERES) of Vall d'Hebron Research Institute and a the sepsis gropus of Rovir

News

Vall d’ Hebron Researchers present important advances against cancer

Researchers from Vall d'Hebron Research Institute (VHIR), who have developed 9 of the 31 research projects about cancer, thanks to the donations collected at La Marató 2004, expose results obtained at the 11th Symposium La Marato Foundation of TV3.During the day, that takes places at Cosmocaixa’s mu

News

L'Institut de Recerca i el BSC exploren vies de col·laboració

Representants de l’Institut de Recerca Vall d’Hebron (IR-HUVH) han visitat les instal·lacions del Barcelona Supercomputing Center – Centro Nacional de Supercomputación (BSCCNS) per explorar possibles vies de col·laboració en el futur. Per part de l’IR-HUVH han assistit el seu director, Joan X. Comel